跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Serlev - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Serlev
Approved
STANDARD
Serlev
The Searle Company Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1aa6cc09e8a6e10c
Company
The Searle Company Limited
Type
Standard
Approval Details
Approval Id
1aa6cc09e8a6e10c
Drug Approval Philippines Name
Serlev
Product Name
Serlev
Registration Number
DRP-5331
Brand Name
Serlev
Generic Name
Levofloxacin (as hemihydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
The Searle Company Limited
Importer
Ambica International Trading Corp.
Distributor
Ambica International Trading Corp.
Company Detail Path
/organization/the-searle-company-limited
Issuance Date
23 June 2024
Expiry Date
02 June 2029
Pharmacologic Category
Antibacterial (Fluoroquinolone)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1aa6cc09e8a6e10c
Type
Standard
Back to Philippines FDA Approvals